Three patients received programmed cell death protein 1 (PD1) inhibitor after induction therapy of HLH-2004 or combined chemotherapy, whereby two cases survived for more than 2 years and one patient died within 3 months. Here, PDCD1 is linked to hemophagocytic syndrome.